Let us also not forget the Series C shares... created, I believe, for partnership. This is how I see the next few months going...
1. Peer Reviewed Journal Article 2. Commercial manufacturing approved in UK 3. Acceptance of Application to manufacture and sell DCVAX-L for Brain tumors in UK (MAA?) 4. Approval of said Application 5. $MRK buys all Series C shares for $2 Billion (or more) to partner with NWBO... common goes to >$8 instantly 6. NWBO uplists to either DOW or NASDAQ 7. Institutional buyers push pps over $20 8. $MRK buys NWBO for multiple of $20... maybe stock trade of 2 NWBO for 1 MRK...